Skip to main content
Clinical Trials/RBR-427g9ht
RBR-427g9ht
Not Yet Recruiting
N/A

Randomized clinical trial evaluating the Surgical Treatment of large-volume Benign Prostatic Hyperplasia: Endoscopic Enucleation with Holmium Laser x Minimally-invasive Simple Prostatectomy x Bipolar Transurethral Resection of Prostate

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 sitesOctober 27, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 27, 2023
End Date
August 1, 2027
Last Updated
2 years ago
Study Type
Intervention
Sex
Male

Investigators

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Eligibility Criteria

Inclusion Criteria

  • Prostatic volume between 80 and 150mL measured by abdominal ultrasound of the prostate. Present at least one indication criteria for surgical treatment of Benign prostatic hyperplasia (BPH): renal failure with bilateral ureterohydronephrosis, recurrent macroscopic hematúria, acute urinary retention, recurrent urinary tract infection secondary to high post\-void volume, moderate to severe voiding urinary symptoms even with clinical treatment interpreted by International Prostate Symptom Score (IPSS) \> 15 and/or maximum urinary flow (Qmax) \< 12mL/s, moderate to severe voiding urinary symptoms interpreted by International Prostate Symptom Score (IPSS) \> 15 and/or maximum urinary flow (Qmax) \< 12mL/s in patients intolerant to pharmacological therapy

Exclusion Criteria

  • Prostate câncer. Neurogenic bladder. Previous prostatic surgeries. Bladder stones. Urethral pathologies. Impossibility of suspending anticoagulants or anti\-platelet agentes

Outcomes

Primary Outcomes

Not specified

Similar Trials